Trademark: PAIGE.AI 1946207
Word
PAIGE.AI
ID
1946207
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
06 August 2018
Registration Date
06 August 2018
Renewal Date
06 August 2028
Owner(s)
Service
Omoi IP Pty Ltd
Goods and Services:
Class 9:
Software; software for use in disease pathology; software for use in diagnosis of diseases, states, or conditions; software for use in evaluation of prognosis relating to diseases, states, or conditions; software for use in monitoring of diseases, states, or conditions; software for use to detect or identify predispositions to diseases, states, or conditions; software for use to detect or determine the recurrence of diseases, states, or conditions; software for use to detect, monitor, or evaluate patients' responses to treatment of diseases, states, or conditions; software for use in clinical management of diseases, states, or conditions; software for use in the selection of treatment for diseases, states, or conditions; software for use in prevention of diseases, states, or conditions; software for use in palliation or treatment of diseases, states or conditions; software for use in research or development in the field of life sciences; software for use in research or development in the field of medicine; software for use in research or development in the field of healthcare; software for use in research or development in the field of cancer; software for use in research or development in the field of oncology; software for use in research or development in the field of pathology
Software; software for use in disease pathology; software for use in diagnosis of diseases, states, or conditions; software for use in evaluation of prognosis relating to diseases, states, or conditions; software for use in monitoring of diseases, states, or conditions; software for use to detect or identify predispositions to diseases, states, or conditions; software for use to detect or determine the recurrence of diseases, states, or conditions; software for use to detect, monitor, or evaluate patients' responses to treatment of diseases, states, or conditions; software for use in clinical management of diseases, states, or conditions; software for use in the selection of treatment for diseases, states, or conditions; software for use in prevention of diseases, states, or conditions; software for use in palliation or treatment of diseases, states or conditions; software for use in research or development in the field of life sciences; software for use in research or development in the field of medicine; software for use in research or development in the field of healthcare; software for use in research or development in the field of cancer; software for use in research or development in the field of oncology; software for use in research or development in the field of pathology
Class 42:
Software as a service (SaaS); software as a service (SaaS) services, namely, software for use in disease pathology; software as a service (SaaS) services, namely, software for use in diagnosis of diseases, states, or conditions; software as a service (SaaS) services, namely, software for use in evaluation of prognosis relating to diseases, states, or conditions; software as a service (SaaS) services, namely, software for use in monitoring of diseases, states, or conditions; software as a service (SaaS) services, namely, software for use to detect or identify predispositions to diseases, states, or conditions; software as a service (SaaS) services, namely, software to detect the recurrence of diseases, states, or conditions; software as a service (SaaS) services, namely, software to detect, monitor, or evaluate patients' responses to treatment of diseases, states, or conditions; software as a service (SaaS) services, namely, software for use in clinical management of diseases, states, or conditions; software as a service (SaaS) services, namely, software for use in the selection of treatment of diseases, states, or conditions; software as a service (SaaS) services, namely, software for use in prevention of diseases, states, or conditions; software as a service (SaaS) services, namely, software for use in palliation or treatment of diseases, states, or conditions; software as a service (SaaS) services, namely, software for use in research or development in the field of life sciences; software as a service (SaaS) services, namely, software for use in research or development in the field of medicine; software as a service (SaaS) services, namely, software for use in research or development in the field of healthcare; software as a service (SaaS) services, namely, software for use in research or development in the field of cancer; software as a service (SaaS) services, namely, software as a service (SaaS) services, namely, software for use in research or development in the field of oncology; software as a service (SaaS) services, namely, software for use in research or development in the field of pathology; design and development of computer software and artificial intelligence; medical research; research and development services in the field of pathology; research and development services in the field of medicine; research and development services in the field of cancer; research and development services in the field of healthcare; research and development services in the field of life sciences; research and development services in the field of oncology; medical and scientific research services in the field of pathology; medical and scientific research services in the field of cancer; medical and scientific research services in the field of healthcare; medical and scientific research services in the field of life sciences; medical and scientific research services in the field of oncology; research and development of technology in the field of pathology; research and development of technology in the field of medicine; research and development of technology in the field of cancer; research and development of technology in the field of healthcare; research and development of technology in the field of life sciences; research and development of technology in the field of oncology; providing medical and scientific research information via the internet; medical and scientific testing services for research purposes
Software as a service (SaaS); software as a service (SaaS) services, namely, software for use in disease pathology; software as a service (SaaS) services, namely, software for use in diagnosis of diseases, states, or conditions; software as a service (SaaS) services, namely, software for use in evaluation of prognosis relating to diseases, states, or conditions; software as a service (SaaS) services, namely, software for use in monitoring of diseases, states, or conditions; software as a service (SaaS) services, namely, software for use to detect or identify predispositions to diseases, states, or conditions; software as a service (SaaS) services, namely, software to detect the recurrence of diseases, states, or conditions; software as a service (SaaS) services, namely, software to detect, monitor, or evaluate patients' responses to treatment of diseases, states, or conditions; software as a service (SaaS) services, namely, software for use in clinical management of diseases, states, or conditions; software as a service (SaaS) services, namely, software for use in the selection of treatment of diseases, states, or conditions; software as a service (SaaS) services, namely, software for use in prevention of diseases, states, or conditions; software as a service (SaaS) services, namely, software for use in palliation or treatment of diseases, states, or conditions; software as a service (SaaS) services, namely, software for use in research or development in the field of life sciences; software as a service (SaaS) services, namely, software for use in research or development in the field of medicine; software as a service (SaaS) services, namely, software for use in research or development in the field of healthcare; software as a service (SaaS) services, namely, software for use in research or development in the field of cancer; software as a service (SaaS) services, namely, software as a service (SaaS) services, namely, software for use in research or development in the field of oncology; software as a service (SaaS) services, namely, software for use in research or development in the field of pathology; design and development of computer software and artificial intelligence; medical research; research and development services in the field of pathology; research and development services in the field of medicine; research and development services in the field of cancer; research and development services in the field of healthcare; research and development services in the field of life sciences; research and development services in the field of oncology; medical and scientific research services in the field of pathology; medical and scientific research services in the field of cancer; medical and scientific research services in the field of healthcare; medical and scientific research services in the field of life sciences; medical and scientific research services in the field of oncology; research and development of technology in the field of pathology; research and development of technology in the field of medicine; research and development of technology in the field of cancer; research and development of technology in the field of healthcare; research and development of technology in the field of life sciences; research and development of technology in the field of oncology; providing medical and scientific research information via the internet; medical and scientific testing services for research purposes
Class 44:
Medical services; cancer therapy services; medical testing; medical testing for the diagnosis of diseases, states, or conditions; medical testing for evaluation of prognosis relating to diseases, states, or conditions; medical testing for the monitoring of diseases, states, or conditions; medical testing to detect or identify predispositions to diseases, states, or conditions; medical testing to detect or determine the recurrence of diseases, states, or conditions; medical testing to detect, monitor, or evaluate responses to treatment of diseases, states, or conditions; medical testing to evaluate clinical management of diseases, states, or conditions; medical testing for selection of treatment for diseases, states, or conditions; medical testing to evaluate or facilitate prevention of diseases, states, or conditions; medical testing to select, facilitate, monitor, or evaluate palliation or treatment of diseases, states or conditions; medical testing in the field of cancer; medical testing in the field of oncology; medical diagnostic testing, monitoring, or reporting services; medical analysis or advisory services in the field of cancer; medical analysis or advisory services in the field of oncology; medical analysis or advisory services for medical treatment; medical analysis or advisory services for the diagnosis of diseases, states, or conditions; medical analysis or advisory services for the evaluation of prognosis relating to diseases, states, or conditions; medical analysis or advisory services relating to monitoring diseases, states, or conditions; medical analysis or advisory services relating to the detection or identification of predispositions to diseases, states, or conditions; medical analysis or advisory services relating to the detection or determination of the recurrence of diseases, states, or conditions; medical analysis or advisory services relating to the detection, monitoring, or evaluation of responses to treatment of diseases, states, or conditions; medical analysis or advisory services relating to the clinical management of diseases, states, or conditions; medical analysis or advisory services relating to the selection of treatment for diseases, states, or conditions; medical analysis or advisory services relating to the prevention of diseases, states, or conditions; medical analysis or advisory services relating to the palliation or treatment of diseases, states or conditions; qualitative image analysis in the field of digital pathology for medical purposes; quantitative image analysis in the field of digital pathology for medical purposes; electronic scanning of clinical pathology slides; analysis of clinical pathology slides
Medical services; cancer therapy services; medical testing; medical testing for the diagnosis of diseases, states, or conditions; medical testing for evaluation of prognosis relating to diseases, states, or conditions; medical testing for the monitoring of diseases, states, or conditions; medical testing to detect or identify predispositions to diseases, states, or conditions; medical testing to detect or determine the recurrence of diseases, states, or conditions; medical testing to detect, monitor, or evaluate responses to treatment of diseases, states, or conditions; medical testing to evaluate clinical management of diseases, states, or conditions; medical testing for selection of treatment for diseases, states, or conditions; medical testing to evaluate or facilitate prevention of diseases, states, or conditions; medical testing to select, facilitate, monitor, or evaluate palliation or treatment of diseases, states or conditions; medical testing in the field of cancer; medical testing in the field of oncology; medical diagnostic testing, monitoring, or reporting services; medical analysis or advisory services in the field of cancer; medical analysis or advisory services in the field of oncology; medical analysis or advisory services for medical treatment; medical analysis or advisory services for the diagnosis of diseases, states, or conditions; medical analysis or advisory services for the evaluation of prognosis relating to diseases, states, or conditions; medical analysis or advisory services relating to monitoring diseases, states, or conditions; medical analysis or advisory services relating to the detection or identification of predispositions to diseases, states, or conditions; medical analysis or advisory services relating to the detection or determination of the recurrence of diseases, states, or conditions; medical analysis or advisory services relating to the detection, monitoring, or evaluation of responses to treatment of diseases, states, or conditions; medical analysis or advisory services relating to the clinical management of diseases, states, or conditions; medical analysis or advisory services relating to the selection of treatment for diseases, states, or conditions; medical analysis or advisory services relating to the prevention of diseases, states, or conditions; medical analysis or advisory services relating to the palliation or treatment of diseases, states or conditions; qualitative image analysis in the field of digital pathology for medical purposes; quantitative image analysis in the field of digital pathology for medical purposes; electronic scanning of clinical pathology slides; analysis of clinical pathology slides